Envestnet Portfolio Solutions Inc. Has $639,000 Holdings in Encompass Health Corporation (NYSE:EHC)

Envestnet Portfolio Solutions Inc. cut its holdings in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 33.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,311 shares of the company's stock after selling 3,177 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in Encompass Health were worth $639,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. T. Rowe Price Investment Management Inc. bought a new stake in Encompass Health in the fourth quarter valued at $152,953,000. Norges Bank bought a new stake in Encompass Health in the fourth quarter valued at $100,637,000. Raymond James Financial Inc. bought a new stake in Encompass Health in the fourth quarter valued at $77,944,000. Farallon Capital Management LLC grew its position in Encompass Health by 15,266.7% in the fourth quarter. Farallon Capital Management LLC now owns 461,000 shares of the company's stock valued at $42,573,000 after acquiring an additional 458,000 shares during the period. Finally, AQR Capital Management LLC grew its position in Encompass Health by 136.8% in the fourth quarter. AQR Capital Management LLC now owns 689,206 shares of the company's stock valued at $63,648,000 after acquiring an additional 398,154 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently issued reports on EHC. UBS Group upped their price target on Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a research note on Monday, April 28th. Barclays upped their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. Truist Financial reaffirmed a "buy" rating and set a $135.00 price target (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research note on Thursday, June 5th. Finally, Royal Bank Of Canada upped their price target on Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Eight research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $127.00.

Insider Activity

In related news, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the transaction, the insider now owns 11,958 shares in the company, valued at $1,394,422.38. The trade was a 26.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP John Patrick Darby sold 10,000 shares of the company's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president now owns 79,710 shares in the company, valued at $9,149,910.90. This trade represents a 11.15% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 132,663 shares of company stock worth $16,034,082. 2.00% of the stock is owned by corporate insiders.

Encompass Health Trading Up 0.7%

NYSE EHC opened at $121.54 on Friday. The business's 50-day moving average price is $117.22 and its two-hundred day moving average price is $104.49. Encompass Health Corporation has a 12 month low of $82.74 and a 12 month high of $123.13. The firm has a market capitalization of $12.25 billion, a PE ratio of 25.11, a price-to-earnings-growth ratio of 2.45 and a beta of 0.89. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.81.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The company had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the prior year, the company earned $1.12 EPS. The firm's revenue for the quarter was up 10.6% compared to the same quarter last year. On average, analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.56%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.